Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Non Operating Income (2020 - 2025)

Maxcyte (MXCT) has disclosed Non Operating Income for 6 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 29.25% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, down 28.35% year-over-year, with the annual reading at $7.3 million for FY2025, 28.35% down from the prior year.
  • Non Operating Income for Q4 2025 was $1.6 million at Maxcyte, down from $1.7 million in the prior quarter.
  • The five-year high for Non Operating Income was $2.8 million in Q4 2023, with the low at -$732500.0 in Q1 2021.
  • Average Non Operating Income over 5 years is $1.5 million, with a median of $1.9 million recorded in 2022.
  • The sharpest move saw Non Operating Income skyrocketed 10506.52% in 2022, then tumbled 30.57% in 2025.
  • Over 5 years, Non Operating Income stood at $80800.0 in 2021, then soared by 2302.35% to $1.9 million in 2022, then skyrocketed by 45.18% to $2.8 million in 2023, then dropped by 18.24% to $2.3 million in 2024, then decreased by 29.25% to $1.6 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $1.6 million, $1.7 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.